Medpace Holdings
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Medpace Holdings generated cash of $433,374,000, which is more than the previous year. Cash used in financing activities reached the amount of -$182,642,000 last year. Net change in cash is therefore $217,184,000.
Cash Flow
| 2013 | 98.14M | -4.47M | -95.85M |
|---|---|---|---|
| 2015 | 84.11M | -6.43M | -116.48M |
| 2016 | 91.73M | -13.42M | -58.00M |
| 2017 | 97.38M | -12.23M | -97.82M |
| 2018 | 156.58M | -16.97M | -141.58M |
| 2019 | 201.86M | -19.14M | -73.91M |
| 2020 | 258.67M | -31.21M | -82.28M |
| 2021 | 263.32M | -31.36M | -44.45M |
| 2022 | 388.05M | -38.74M | -775.77M |
| 2023 | 433.37M | -34.62M | -182.64M |
MEDP Cash Flow Statement (2013 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 28.26M | 461.30M | 277.76M | 131.92M | 23.28M | 26.49M | 37.40M | 17.73M | 54.28M | 25.88M |
Operating activities | ||||||||||
Net income | 282.81M | 245.36M | 181.84M | 145.38M | 100.44M | 73.18M | 39.12M | 13.42M | -8.67M | 24.84M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 26.32M | 22.34M | 21.11M | 19.52M | 23.18M | 38.80M | 46.47M | 58.11M | 69.52M | 30.51M |
Stock-based compensation expense | 20.51M | 21.41M | 14.46M | 13.78M | 20.74M | 0 | 4.46M | 9.81M | 22.32M | 1.95M |
| Deferred income tax benefit | 20.51M | 21.41M | 14.46M | 13.78M | 20.74M | 0 | 4.46M | 9.81M | 22.32M | 1.95M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -48.28M | -66.92M | -24.98M | -5.53M | -21.25M | -27.04M | -2.89M | -13.72M | 337K | 0 |
Inventories | 66.19M | 0 | 24.98M | 5.53M | 21.25M | 27.78M | 446K | 6.25M | 0 | 0 |
Accounts payable | 1.05M | 6.43M | 1.86M | -2.59M | 4.73M | 1.34M | 4.81M | 691K | 2.48M | 628K |
Cash generated by operating activities | 433.37M | 388.05M | 263.32M | 258.67M | 201.86M | 156.58M | 97.38M | 91.73M | 84.11M | 98.14M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -36.64M | -36.87M | -28.27M | -31.34M | -17.91M | -16.02M | -12.29M | -13.53M | -6.46M | -4.56M |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -34.62M | -38.74M | -31.36M | -31.21M | -19.14M | -16.97M | -12.23M | -13.42M | -6.43M | -4.47M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 17.64M | 15.99M | 6.52M | 0 | 0 | 173.57M | 608K | 1.17M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -144.02M | -847.84M | -62.09M | -98.27M | 0 | 0 | -155.58M | 0 | 0 | 0 |
Repayments of term debt | -50M | 50M | 0 | 0 | -80.43M | -142.18M | 57.62M | -390.60M | -116.05M | -96.43M |
Cash used in financing activities | -182.64M | -775.77M | -44.45M | -82.28M | -73.91M | -141.58M | -97.82M | -58.00M | -116.48M | -95.85M |
Net Change In Cash | 217.18M | -433.03M | 183.53M | 145.84M | 108.63M | -3.21M | -10.91M | 19.67M | -39.40M | -2.02M |
Cash at end of period | 245.44M | 28.26M | 461.30M | 277.76M | 131.92M | 23.28M | 26.49M | 37.40M | 14.88M | 23.85M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |